Liver transplantation in patients with non-neoplastic portal vein thrombosis: 20 years of experience in a single center.


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
01 2022
Historique:
revised: 14 09 2021
received: 18 05 2021
accepted: 25 09 2021
pubmed: 12 10 2021
medline: 3 2 2022
entrez: 11 10 2021
Statut: ppublish

Résumé

The Yerdel classification is widely used for describing the severity of portal vein thrombosis (PVT) in liver transplant (LT) candidates, but might not accurately predict transplant outcome. We retrospectively analyzed data regarding 97 adult patients with PVT who underwent LT, investigating whether the complexity of portal reconstruction could better correlate with transplant outcome than the site and extent of the thrombosis. 79/97 (80%) patients underwent thrombectomy and anatomical anastomosis (TAA), 18/97 (20%) patients underwent non-anatomical physiological reconstructions (non-TAA). PVT Yerdel grade was 1-2 in 72/97 (74%) patients, and 3-4 in 25/97 (26%) patients. Univariate analysis revealed higher 30-day mortality, 90-day mortality, 1-year mortality, and a higher rate of severe early complications in the non-TAA group than in the TAA group (p = .018, .001, .014, .009, respectively). In the model adjusted for PVT Yerdel grade, non-TAA remained independently associated with higher 30-day, 90-day, and 1-year mortality (p = .021, .007, and .015, respectively). The portal vein re-thrombosis and overall patient and graft survival rates were similar. In our experience, the complexity of portal reconstruction better correlated with transplant outcome than the Yerdel classification, which did not even appear to be a reliable predictor of the surgical complexity and technique.

Sections du résumé

BACKGROUND
The Yerdel classification is widely used for describing the severity of portal vein thrombosis (PVT) in liver transplant (LT) candidates, but might not accurately predict transplant outcome.
METHODS
We retrospectively analyzed data regarding 97 adult patients with PVT who underwent LT, investigating whether the complexity of portal reconstruction could better correlate with transplant outcome than the site and extent of the thrombosis.
RESULTS
79/97 (80%) patients underwent thrombectomy and anatomical anastomosis (TAA), 18/97 (20%) patients underwent non-anatomical physiological reconstructions (non-TAA). PVT Yerdel grade was 1-2 in 72/97 (74%) patients, and 3-4 in 25/97 (26%) patients. Univariate analysis revealed higher 30-day mortality, 90-day mortality, 1-year mortality, and a higher rate of severe early complications in the non-TAA group than in the TAA group (p = .018, .001, .014, .009, respectively). In the model adjusted for PVT Yerdel grade, non-TAA remained independently associated with higher 30-day, 90-day, and 1-year mortality (p = .021, .007, and .015, respectively). The portal vein re-thrombosis and overall patient and graft survival rates were similar.
DISCUSSION
In our experience, the complexity of portal reconstruction better correlated with transplant outcome than the Yerdel classification, which did not even appear to be a reliable predictor of the surgical complexity and technique.

Identifiants

pubmed: 34633110
doi: 10.1111/ctr.14501
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14501

Informations de copyright

© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Ponziani FR, Zocco MA, Senzolo M, Pompili M, Gasbarrini A, Avolio AW. Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up. Transplantation Rev (Orlando). 2014;28:92-101.
Rodriguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation. 2012;94:1145-1153.
Chen H, Turon F, Hernandez-Gea V, et al. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl. 2016;22:352-365.
Zanetto A, Rodriguez-Kastro KI, Germani G, et al. Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis. Transpl Int. 2018;31:1318-1329.
D'Amico G, Hassan A, Diago Uso T, et al. Renoportal anastomosis in liver transplantation and its impact on patient outcomes: a systematic literature review. Transpl Int. 2019;32:117-127.
Stieber AC, Zetti G, Todo S, et al. The spectrum of portal vein thrombosis in liver transplantation. Ann Surg. 1991;213:199-206.
Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology. 1992;16:1195-1198.
Gayowski TJ, Marino IR, Doyle HR, et al. A high incidence of portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res. 1996;2:333-338.
Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation. 2000;69:1873-1881.
Jamieson N. Changing perspectives in portal vein thrombosis and liver transplantation. Transplantation. 2000;69:1772-1774.
Charco R, Fuster J, Fondevila C, Ferrer J, Mans E, Garcia-Valdecasas JC. Portal vein thrombosis in liver transplantation. Transplant Proc. 2005;37:3904-3905.
Bauer J, Johnson S, Durham J, et al. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl. 2006;12:1544-1551.
Ma J, Yan Z, Luo J, Liu Q, Wang J, Qiu S. Rational classification of portal vein thrombosis and its clinical significance. PLoS One. 2014;9:e112501.
Sarin SK, Philips CA, Kamath PS, et al. Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis. Gastroenterology. 2016;151:574-577.
Bhangui P, Lim C, Levesque E, et al. Novel classification of non-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation. J Hepatol. 2019;71:1038-1050.
Teng F, Sun K, Fu Z. Tailored classification of portal vein thrombosis for liver transplantation: focus on strategies for portal vein inflow reconstruction. World J Gastroenterol. 2020;26:2691-2701.
Dumortier J, Czyglik O, Poncet G, et al. Eversion thrombectomy for portal vein thrombosis during liver transplantation. Am J Transplant. 2002;2:934-938.
Pan C, Shi Y, Zhang JJ, et al. Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China. Transplant Proc. 2009;41:3761-3765.
Dokmak S, Aussilhou B, Dondero F, Francoz C, Durand F, Belghiti J. Portomesenteric shunt for liver transplantation and complete portal vein thrombosis. Transplantation. 2013;96:e68-e69.
Alexopoulos SP, Thomas E, Berry E, Whang G, Matsuoka L. The portal vein-variceal anastomosis: an important technique for establishing portal vein inflow. Clin Transplant. 2014;28:52-57.
Moon DB, Lee SG, Ahn CS, et al. Restoration of portal flow using a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric thrombosis. Liver Transpl. 2014;20:612-615.
Paskonis M, Jurgaitis J, Mehrabi A, et al. Surgical strategies for liver transplantation in the case of portal vein thrombosis-current role of cavoportal hemitransposition and renoportal anastomosis. Clin Transplant. 2006;20:551-562.
Quintini C, Spaggiari M, Hashimoto K, et al. Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: an analysis of 10 patients. Liver Transpl. 2015;21:344-352.
McKenna G. Making the extraordinary, ordinary: renoportal bypass for complete portal vein thrombosis. Liver Transpl. 2015;21:275-276.
Selvaggi G, Weppler D, Nishida S, et al. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis. Am J Transplant. 2007;7:454-460.
Paloyo S, Nishida S, Fan J, et al. Portal vein arterialization using an accessory right hepatic artery in liver transplantation. Liver Transpl. 2013;19:773-775.
Dindo D, Demartines N, Clavien P. Classification of surgical complications - a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
Skillicorn C. Do the terms “proximal” and “distal” cause confusion amongst radiologists and other clinicians? Clin Radiol. 2009;64:397-402.
Ravaioli M, Zanello M, Grazi GL, et al. Portal vein thrombosis and liver transplantation - evolution during 10 years of experience at the University of Bologna. Ann Surg. 2011;253:378-384.
Vianna RM, Mangus RS, Chandrashekhar K, Fridell JA, Beduschi T, Tector JA. Multivisceral transplantation for diffuse portomesenteric thrombosis. Ann Surg. 2012;255:1144-1150.
Azoulay D, Quintini C, Rayar M, et al. Renoportal anastomosis during liver transplantation in patients with portal vein thrombosis: first long-term results from a multicenter study. Ann Surg. Published online February 10, 2021.

Auteurs

Domenico Pinelli (D)

Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Stefania Camagni (S)

Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Annalisa Amaduzzi (A)

Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Fabio Frosio (F)

Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Laura Fontanella (L)

Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Greta Carioli (G)

FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Michela Guizzetti (M)

Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Marco Fabrizio Zambelli (MF)

Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Mara Giovanelli (M)

Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Stefano Fagiuoli (S)

Gastroenterology Hepatology and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Michele Colledan (M)

Department of Organ Failure and Transplantation, ASST Papa Giovanni XXIII, Bergamo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH